BioResearch
Chimeric Molecule Shows Chemotherapy Potential
A recent study describes the development of a new cancer chemotherapy method based on a genetically engineered fusion molecule that is a combination of a specific anti-cancer cell monoclonal antibody on one end and a major histocompatibility complex (MHC) viral antigen on the other. More...30 Jun 2004
In Other News
Heat Shock Protein May Be Target for Chemotherapy
Epigenetic Therapy: a New Approach to Cancer Treatment
New Filtration System Removes Prions
Liposome-Mediated Gene Therapy for Brain Tumors
Transformed Stem Cells Express Nerve Cell Proteins
Carl Zeiss Acquires Bio-Rad's Cell Science Division
DuPont to Acquire Verdia Subsidiary of Maxygen
Yeast Protein Controls Prion Formation
Study of Genetic Basis for Adverse Drug Reactions
Virus Linked to Breast Cancer Suggests a Vaccine
Britain Invests in Stem Cell Research
New Cancer Drugs May Target Tyrosine Phosphatases
New Target Protein Identified in Cancerous Cells
Easy Purification and Storage of Blood DNA
Drug Collaboration Based on Natural Products
Studies Reveal Potential Therapies for Pancreatic Cancer
Rodent-Specific Beta Amyloid Antibody
Collaboration on GPCRs and Ion Channel Technology
Merck and Genetronics Collaborate on DNA Delivery System
New Therapy Boosts Function in Paralyzed Rats
Short Telomeres Linked to Cancer Development
Gene Analysis Links Transporter Protein to Alzheimer's Disease
Blocking Master Switch Helps Kill Tumors
BioResearch brings the latest research news on the genome, proteome, metabolome, on drug discovery, and therapeutics. Biotech researchers, lab administrators, technologists, drug manufacturers, and suppliers can find the latest research news and information related to their fields of endeavor here.







